Shiguo Zhu Selected Research

Shiguo Zhu Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 07/2003
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 11/2017
5	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2016
3	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2007
2	Ischemic Stroke 01/2021 - 01/2018
1	Bites and Stings (Sting) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Pain (Aches) 01/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2018
1	Brain Injuries (Brain Injury) 01/2018
1	Brain Infarction 01/2018
1	Ischemia 01/2018
1	Carcinoma (Carcinomatosis) 03/2015
1	Sarcoma (Soft Tissue Sarcoma) 03/2015
1	Osteosarcoma (Osteogenic Sarcoma) 03/2015
1	Lymphoma (Lymphomas) 07/2014
1	Inflammation (Inflammations) 07/2014
1	Carcinogenesis 07/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2013
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2012
1	Nasopharyngeal Carcinoma 09/2003

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 07/2007
6	Biological ProductsIBA 01/2022 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2007
4	CytokinesIBA 01/2020 - 01/2008
4	Interleukin-12 (IL 12)IBA 02/2014 - 07/2007
2	rocaglamideIBA 01/2022 - 01/2018
2	InterferonsIBA 01/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 03/2021 - 01/2020
2	LigandsIBA 03/2015 - 07/2013
2	Complementary DNA (cDNA)IBA 01/2015 - 09/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2014 - 07/2007
2	Complement System Proteins (Complement)IBA 05/2008 - 05/2008
2	Peptides (Polypeptides)IBA 05/2008 - 05/2008
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	rediocide AIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 12/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021
1	astragaloside AIBA 01/2021
1	tanshinoneIBA 01/2021
1	3-ingenyl angelateIBA 12/2020
1	20-deoxyingenolIBA 12/2020
1	EndorphinsIBA 01/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	LuciferasesIBA 01/2019
1	buyang huanwuIBA 01/2018
1	GelatinIBA 01/2018
1	Evans Blue (Blue, Evans)FDA Link 01/2018
1	Tight Junction ProteinsIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Chemokine CXCL10IBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 11/2017
1	ailanthoneIBA 11/2017
1	ingenolIBA 01/2017
1	IsoenzymesIBA 01/2017
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 10/2016
1	sanguinarineIBA 10/2016
1	micaIBA 03/2015
1	Histones (Histone)IBA 03/2015
1	entinostat (MS 275)IBA 03/2015
1	benzamideIBA 03/2015
1	Histone Deacetylase InhibitorsIBA 03/2015
1	interleukin-21 (interleukin 21)IBA 07/2014
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2014
1	NK Cell Lectin-Like Receptor Subfamily KIBA 02/2014
1	Immunoglobulins (Immunoglobulin)IBA 07/2013
1	KIR ReceptorsIBA 07/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2013
1	Natural Killer Cell ReceptorsIBA 07/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2012
1	Interleukin-27 (Interleukin 27)IBA 03/2010
1	STAT1 Transcription FactorIBA 07/2007
1	1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA 07/2003

Therapy/Procedure

11	Immunotherapy 01/2022 - 07/2013
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2021 - 04/2019
2	Therapeutics 01/2021 - 01/2020
1	Acupuncture Points (Acupuncture Point) 01/2021
1	Moxibustion 01/2021
1	Electroacupuncture 01/2020
1	Intraperitoneal Injections 02/2014